Organon (OGN)
Organon on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as pharmaceutical preparations.
18.8M
Short interest
settlement 2026-10-15
8.6
Days to cover
-0.4 days vs prior
37.5%
Short share of volume
2026-11-02
475
Fails to deliver
settlement 2026-10-07
Mon 9 Nov
Next earnings
estimated date
-$200K
Insider flow, 90 days
0 buys, 1 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in OGN is 18,817,326 shares, up 1,287,587 shares over the last month. Over the last 48 readings it ranged from 12,151,104 shares (15 October 2025) to 22,133,518 shares (31 March 2026). At the reported average volume of 2.2M shares a day that is 8.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ogn" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 18,817,326 | -0.8% | 2,184,862 | 8.61 |
| 2026-09-30 | 18,961,096 | +8.2% | 2,094,230 | 9.05 |
| 2026-09-15 | 17,529,739 | +5.0% | 3,170,923 | 5.53 |
| 2026-08-31 | 16,695,178 | +10.3% | 3,259,610 | 5.12 |
| 2026-08-14 | 15,138,620 | -9.9% | 2,483,394 | 6.10 |
| 2026-07-31 | 16,806,674 | +3.5% | 2,714,888 | 6.19 |
| 2026-07-15 | 16,243,541 | -4.9% | 2,546,842 | 6.38 |
| 2026-06-30 | 17,087,338 | -10.1% | 2,471,178 | 6.91 |
| 2026-06-15 | 19,010,196 | +5.2% | 2,416,048 | 7.87 |
| 2026-05-29 | 18,074,491 | -9.8% | 3,288,657 | 5.50 |
| 2026-05-15 | 20,035,860 | +2.8% | 6,325,569 | 3.17 |
| 2026-04-30 | 19,493,725 | +4.8% | 25,050,454 | 1.00 |
| 2026-04-15 | 18,609,663 | -15.9% | 9,901,209 | 1.88 |
| 2026-03-31 | 22,133,518 | +14.5% | 3,663,719 | 6.04 |
| 2026-03-13 | 19,323,061 | +18.7% | 3,101,063 | 6.23 |
| 2026-02-27 | 16,278,054 | -7.2% | 4,361,331 | 3.73 |
| 2026-02-13 | 17,545,543 | +21.9% | 5,311,139 | 3.30 |
| 2026-01-30 | 14,393,046 | -7.4% | 7,137,861 | 2.02 |
| 2026-01-15 | 15,544,916 | -11.4% | 6,368,394 | 2.44 |
| 2025-12-31 | 17,547,130 | +5.7% | 4,258,048 | 4.12 |
| 2025-12-15 | 16,602,771 | +2.3% | 4,704,076 | 3.53 |
| 2025-11-28 | 16,230,867 | +4.1% | 4,983,692 | 3.26 |
| 2025-11-14 | 15,587,869 | +19.0% | 8,008,022 | 1.95 |
| 2025-10-31 | 13,100,266 | +7.8% | 9,172,081 | 1.43 |
| 2025-10-15 | 12,151,104 | -5.2% | 3,391,667 | 3.58 |
| 2025-09-30 | 12,815,979 | -6.4% | 3,966,141 | 3.23 |
| 2025-09-15 | 13,694,797 | -8.2% | 3,490,907 | 3.92 |
| 2025-08-29 | 14,911,397 | +3.9% | 3,865,889 | 3.86 |
| 2025-08-15 | 14,346,223 | -4.4% | 5,570,671 | 2.58 |
| 2025-07-31 | 15,006,377 | +2.1% | 3,643,579 | 4.12 |
| 2025-07-15 | 14,697,025 | -7.7% | 3,689,866 | 3.98 |
| 2025-06-30 | 15,917,721 | -0.2% | 3,531,524 | 4.51 |
| 2025-06-13 | 15,952,116 | -8.8% | 4,460,607 | 3.58 |
| 2025-05-30 | 17,486,892 | +9.6% | 5,409,011 | 3.23 |
| 2025-05-15 | 15,960,972 | -19.0% | 11,712,893 | 1.36 |
| 2025-04-30 | 19,699,855 | +13.0% | 4,483,697 | 4.39 |
| 2025-04-15 | 17,432,896 | +15.2% | 4,610,675 | 3.78 |
| 2025-03-31 | 15,133,818 | -17.6% | 4,381,120 | 3.45 |
| 2025-03-14 | 18,361,214 | +2.9% | 3,598,906 | 5.10 |
| 2025-02-28 | 17,838,082 | -3.3% | 3,246,926 | 5.49 |
| 2025-02-14 | 18,450,673 | +11.3% | 3,373,782 | 5.47 |
| 2025-01-31 | 16,583,192 | -9.0% | 2,244,219 | 7.39 |
| 2025-01-15 | 18,231,810 | -0.6% | 2,928,082 | 6.23 |
| 2024-12-31 | 18,341,262 | +20.1% | 5,652,322 | 3.24 |
| 2024-12-13 | 15,269,663 | +11.6% | 3,144,004 | 4.86 |
| 2024-11-29 | 13,677,011 | -7.1% | 2,612,398 | 5.24 |
| 2024-11-15 | 14,719,416 | +4.0% | 3,630,739 | 4.05 |
| 2024-10-31 | 14,151,407 | +12.9% | 2,192,472 | 6.45 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of OGN volume is 37.5%, down 4.1 points over the last five sessions. Over the last 30 readings it ranged from 29.0% (24 September 2026) to 74.6% (16 October 2026). The latest reading is 15.9 points below the 30-session average of 53.4%, on 917K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 344K | 917K | 37.5% | 927 |
| 2026-10-30 | 346K | 612K | 56.6% | 1,754 |
| 2026-10-29 | 305K | 982K | 31.0% | 19 |
| 2026-10-28 | 1.0M | 1.7M | 58.2% | 0 |
| 2026-10-27 | 359K | 703K | 51.0% | 115 |
| 2026-10-26 | 156K | 374K | 41.7% | 509 |
| 2026-10-23 | 138K | 380K | 36.3% | 30 |
| 2026-10-22 | 390K | 767K | 50.8% | 0 |
| 2026-10-21 | 362K | 738K | 49.0% | 366 |
| 2026-10-20 | 460K | 868K | 53.0% | 4,761 |
| 2026-10-19 | 581K | 1.3M | 43.5% | 1,133 |
| 2026-10-16 | 608K | 815K | 74.6% | 555 |
| 2026-10-15 | 265K | 496K | 53.3% | 132 |
| 2026-10-14 | 421K | 699K | 60.2% | 0 |
| 2026-10-13 | 1.2M | 1.7M | 70.0% | 0 |
| 2026-10-12 | 166K | 334K | 49.6% | 499 |
| 2026-10-09 | 1.2M | 2.0M | 60.1% | 6,533 |
| 2026-10-08 | 367K | 621K | 59.2% | 1,140 |
| 2026-10-07 | 497K | 1.0M | 49.5% | 297 |
| 2026-10-06 | 566K | 823K | 68.7% | 268 |
| 2026-10-05 | 276K | 578K | 47.8% | 77 |
| 2026-10-02 | 548K | 758K | 72.3% | 1,170 |
| 2026-10-01 | 526K | 740K | 71.0% | 63 |
| 2026-09-30 | 436K | 889K | 49.1% | 5,240 |
| 2026-09-29 | 252K | 539K | 46.7% | 283 |
| 2026-09-28 | 541K | 923K | 58.6% | 17,614 |
| 2026-09-25 | 329K | 626K | 52.5% | 1,817 |
| 2026-09-24 | 205K | 708K | 29.0% | 6,311 |
| 2026-09-23 | 284K | 400K | 70.9% | 183 |
| 2026-09-22 | 280K | 551K | 50.7% | 72 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 7 October 2026, the fails-to-deliver balance in OGN is 475 shares, up 470 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (8 June 2026) to 28,121 shares (31 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-07 | 475 | $13.74 | $7K |
| 2026-10-06 | 5 | $13.70 | $69 |
| 2026-09-29 | 474 | $13.73 | $7K |
| 2026-09-04 | 160 | $13.77 | $2K |
| 2026-09-03 | 21,354 | $13.77 | $294K |
| 2026-08-31 | 28,121 | $13.76 | $387K |
| 2026-08-24 | 10 | $13.75 | $138 |
| 2026-08-14 | 153 | $13.72 | $2K |
| 2026-08-10 | 16,931 | $13.60 | $230K |
| 2026-08-05 | 2 | $13.56 | $27 |
| 2026-07-24 | 289 | $13.56 | $4K |
| 2026-07-23 | 31 | $13.52 | $419 |
| 2026-07-20 | 1 | $13.52 | $14 |
| 2026-07-17 | 383 | $13.49 | $5K |
| 2026-07-09 | 15 | $13.47 | $202 |
| 2026-07-01 | 9 | $13.54 | $122 |
| 2026-06-29 | 46 | $13.50 | $621 |
| 2026-06-23 | 930 | $13.40 | $12K |
| 2026-06-22 | 3,145 | $13.43 | $42K |
| 2026-06-12 | 6,835 | $13.45 | $92K |
| 2026-06-11 | 1,992 | $13.38 | $27K |
| 2026-06-10 | 120 | $13.40 | $2K |
| 2026-06-08 | 1 | $13.36 | $13 |
| 2026-06-01 | 13,377 | $13.34 | $178K |
| 2026-05-22 | 580 | $13.42 | $8K |
| 2026-05-19 | 1,404 | $13.42 | $19K |
| 2026-05-18 | 500 | $13.40 | $7K |
| 2026-05-15 | 318 | $13.36 | $4K |
| 2026-05-14 | 3 | $13.34 | $40 |
| 2026-05-13 | 638 | $13.31 | $8K |
Insider trades
SEC Form 4, newest first. JSONInsiders at OGN reported 1 open-market sell worth $200K in the last 90 days and no open-market buys. Latest filing: Arjona Ferreira Juan Camilo (Head of R&D & CMO) on 2026-08-11.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-11 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Tax withholding | 4K | $13.62 | $56K | 37K |
| 2026-08-11 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Exercise or conversion | 12K | $0.00 | $0 | 42K |
| 2026-08-05 | Drinane Juliana Papa | Head of Mfg & Supply | Sell | 15K | $13.57 | $200K | 18K |
| 2026-05-06 | Holzbaur Lynette | SVP and Corporate Controller | Buy | 26K | $13.35 | $353K | 53K |
| 2026-05-06 | Holzbaur Lynette | SVP and Corporate Controller | Other transaction | 46 | $0.00 | $0 | 26K |
| 2026-05-06 | Holzbaur Lynette | SVP and Corporate Controller | Sell | 26K | $13.35 | $353K | 0 |
| 2026-05-06 | Holzbaur Lynette | SVP and Corporate Controller | Buy | 26K | $13.35 | $353K | 53K |
| 2026-03-31 | Stahler Rachel A | Chief Information Officer | Tax withholding | 4K | $5.70 | $24K | 116K |
| 2026-03-31 | Stahler Rachel A | Chief Information Officer | Exercise or conversion | 12K | $0.00 | $0 | 120K |
| 2026-03-31 | Stahler Rachel A | Chief Information Officer | Tax withholding | 2K | $5.70 | $13K | 108K |
| 2026-03-31 | Stahler Rachel A | Chief Information Officer | Exercise or conversion | 7K | $0.00 | $0 | 110K |
| 2026-03-31 | WALSH MATTHEW M | Chief Financial Officer | Tax withholding | 7K | $5.70 | $42K | 213K |
| 2026-03-31 | WALSH MATTHEW M | Chief Financial Officer | Exercise or conversion | 22K | $0.00 | $0 | 220K |
| 2026-03-31 | WALSH MATTHEW M | Chief Financial Officer | Tax withholding | 4K | $5.70 | $24K | 199K |
| 2026-03-31 | WALSH MATTHEW M | Chief Financial Officer | Exercise or conversion | 12K | $0.00 | $0 | 203K |
| 2026-03-31 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Tax withholding | 4K | $5.70 | $20K | 93K |
| 2026-03-31 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Exercise or conversion | 12K | $0.00 | $0 | 96K |
| 2026-03-31 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Tax withholding | 2K | $5.70 | $10K | 84K |
| 2026-03-31 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Exercise or conversion | 6K | $0.00 | $0 | 86K |
| 2026-03-31 | Nisita Vittorio | Head of Global Business Svcs | Tax withholding | 3K | $5.70 | $16K | 71K |
| 2026-03-31 | Nisita Vittorio | Head of Global Business Svcs | Exercise or conversion | 8K | $0.00 | $0 | 73K |
| 2026-03-31 | Nisita Vittorio | Head of Global Business Svcs | Tax withholding | 2K | $5.70 | $9K | 65K |
| 2026-03-31 | Nisita Vittorio | Head of Global Business Svcs | Exercise or conversion | 5K | $0.00 | $0 | 67K |
| 2026-03-31 | Morrissey Joseph T. Jr. | Interim CEO | Tax withholding | 5K | $5.70 | $27K | 123K |
| 2026-03-31 | Morrissey Joseph T. Jr. | Interim CEO | Exercise or conversion | 17K | $0.00 | $0 | 128K |
| 2026-03-31 | Morrissey Joseph T. Jr. | Interim CEO | Tax withholding | 2K | $5.70 | $13K | 111K |
| 2026-03-31 | Morrissey Joseph T. Jr. | Interim CEO | Exercise or conversion | 8K | $0.00 | $0 | 113K |
| 2026-03-31 | Karp Daniel | Executive VP, Corp. Dev. | Tax withholding | 2K | $5.70 | $12K | 70K |
| 2026-03-31 | Karp Daniel | Executive VP, Corp. Dev. | Exercise or conversion | 7K | $0.00 | $0 | 72K |
| 2026-03-31 | Karp Daniel | Executive VP, Corp. Dev. | Tax withholding | 4K | $5.70 | $20K | 65K |
| 2026-03-31 | Karp Daniel | Executive VP, Corp. Dev. | Exercise or conversion | 11K | $0.00 | $0 | 68K |
| 2026-03-31 | Holzbaur Lynette | SVP and Corporate Controller | Tax withholding | 2K | $5.70 | $11K | 26K |
| 2026-03-31 | Holzbaur Lynette | SVP and Corporate Controller | Exercise or conversion | 7K | $0.00 | $0 | 28K |
| 2026-03-31 | Holzbaur Lynette | SVP and Corporate Controller | Tax withholding | 1K | $5.70 | $7K | 22K |
| 2026-03-31 | Holzbaur Lynette | SVP and Corporate Controller | Exercise or conversion | 4K | $0.00 | $0 | 23K |
| 2026-03-31 | Falcione Aaron | Chief Human Resources Officer | Tax withholding | 4K | $5.70 | $22K | 101K |
| 2026-03-31 | Falcione Aaron | Chief Human Resources Officer | Exercise or conversion | 11K | $0.00 | $0 | 105K |
| 2026-03-31 | Falcione Aaron | Chief Human Resources Officer | Tax withholding | 2K | $5.70 | $13K | 94K |
| 2026-03-31 | Falcione Aaron | Chief Human Resources Officer | Exercise or conversion | 7K | $0.00 | $0 | 96K |
| 2026-03-31 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Tax withholding | 3K | $5.70 | $20K | 33K |
| 2026-03-31 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Exercise or conversion | 10K | $0.00 | $0 | 37K |
| 2026-03-31 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Tax withholding | 2K | $5.70 | $12K | 27K |
| 2026-03-31 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Exercise or conversion | 6K | $0.00 | $0 | 29K |
| 2026-03-31 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Tax withholding | 5K | $5.70 | $27K | 30K |
| 2026-03-31 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Exercise or conversion | 13K | $0.00 | $0 | 35K |
| 2026-03-29 | Stahler Rachel A | Chief Information Officer | Tax withholding | 3K | $5.84 | $16K | 104K |
| 2026-03-29 | Stahler Rachel A | Chief Information Officer | Exercise or conversion | 8K | $0.00 | $0 | 107K |
| 2026-03-29 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Tax withholding | 2K | $5.84 | $13K | 79K |
| 2026-03-29 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Exercise or conversion | 8K | $0.00 | $0 | 82K |
| 2026-03-29 | WALSH MATTHEW M | Chief Financial Officer | Tax withholding | 5K | $5.84 | $30K | 191K |
| 2026-03-29 | WALSH MATTHEW M | Chief Financial Officer | Exercise or conversion | 15K | $0.00 | $0 | 196K |
| 2026-03-29 | Nisita Vittorio | Head of Global Business Svcs | Tax withholding | 2K | $5.84 | $12K | 62K |
| 2026-03-29 | Nisita Vittorio | Head of Global Business Svcs | Exercise or conversion | 6K | $0.00 | $0 | 64K |
| 2026-03-29 | Morrissey Joseph T. Jr. | Interim CEO | Tax withholding | 3K | $5.84 | $16K | 106K |
| 2026-03-29 | Morrissey Joseph T. Jr. | Interim CEO | Exercise or conversion | 10K | $0.00 | $0 | 108K |
| 2026-03-29 | Karp Daniel | Executive VP, Corp. Dev. | Tax withholding | 4K | $5.84 | $26K | 57K |
| 2026-03-29 | Karp Daniel | Executive VP, Corp. Dev. | Exercise or conversion | 14K | $0.00 | $0 | 61K |
| 2026-03-29 | Holzbaur Lynette | SVP and Corporate Controller | Tax withholding | 2K | $5.84 | $9K | 19K |
| 2026-03-29 | Holzbaur Lynette | SVP and Corporate Controller | Exercise or conversion | 5K | $0.00 | $0 | 20K |
| 2026-03-29 | Falcione Aaron | Chief Human Resources Officer | Tax withholding | 3K | $5.84 | $17K | 90K |
| 2026-03-29 | Falcione Aaron | Chief Human Resources Officer | Exercise or conversion | 8K | $0.00 | $0 | 93K |
| 2026-03-29 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Tax withholding | 3K | $5.84 | $16K | 22K |
| 2026-03-29 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Exercise or conversion | 8K | $0.00 | $0 | 25K |
| 2026-03-29 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Tax withholding | 3K | $5.84 | $19K | 21K |
| 2026-03-29 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Exercise or conversion | 9K | $0.00 | $0 | 24K |
| 2026-02-27 | WALSH MATTHEW M | Chief Financial Officer | Tax withholding | 4K | $7.23 | $30K | 181K |
| 2026-02-27 | WALSH MATTHEW M | Chief Financial Officer | Grant | 12K | $0.00 | $0 | 184K |
| 2026-02-27 | WALSH MATTHEW M | Chief Financial Officer | Tax withholding | 15K | $7.17 | $107K | 172K |
| 2026-02-27 | WALSH MATTHEW M | Chief Financial Officer | Grant | 43K | $0.00 | $0 | 187K |
| 2026-02-27 | Stahler Rachel A | Chief Information Officer | Tax withholding | 2K | $7.23 | $16K | 98K |
| 2026-02-27 | Stahler Rachel A | Chief Information Officer | Grant | 7K | $0.00 | $0 | 98K |
| 2026-02-27 | Stahler Rachel A | Chief Information Officer | Tax withholding | 8K | $7.17 | $61K | 92K |
| 2026-02-27 | Stahler Rachel A | Chief Information Officer | Grant | 23K | $0.00 | $0 | 100K |
| 2026-02-27 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Tax withholding | 2K | $7.23 | $13K | 74K |
| 2026-02-27 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Grant | 6K | $0.00 | $0 | 74K |
| 2026-02-27 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Tax withholding | 7K | $7.17 | $49K | 68K |
| 2026-02-27 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Grant | 22K | $0.00 | $0 | 74K |
| 2026-02-27 | Nisita Vittorio | Head of Global Business Svcs | Tax withholding | 2K | $7.23 | $11K | 58K |
| 2026-02-27 | Nisita Vittorio | Head of Global Business Svcs | Grant | 5K | $0.00 | $0 | 58K |
| 2026-02-27 | Nisita Vittorio | Head of Global Business Svcs | Tax withholding | 6K | $7.17 | $45K | 54K |
| 2026-02-27 | Nisita Vittorio | Head of Global Business Svcs | Grant | 16K | $0.00 | $0 | 60K |
| 2026-02-27 | Morrissey Joseph T. Jr. | Interim CEO | Tax withholding | 2K | $7.23 | $16K | 99K |
| 2026-02-27 | Morrissey Joseph T. Jr. | Interim CEO | Grant | 8K | $0.00 | $0 | 99K |
| 2026-02-27 | Morrissey Joseph T. Jr. | Interim CEO | Tax withholding | 8K | $7.17 | $58K | 91K |
| 2026-02-27 | Morrissey Joseph T. Jr. | Interim CEO | Grant | 28K | $0.00 | $0 | 99K |
| 2026-02-27 | Falcione Aaron | Chief Human Resources Officer | Tax withholding | 2K | $7.23 | $17K | 84K |
| 2026-02-27 | Falcione Aaron | Chief Human Resources Officer | Grant | 7K | $0.00 | $0 | 85K |
| 2026-02-27 | Falcione Aaron | Chief Human Resources Officer | Tax withholding | 9K | $7.17 | $62K | 78K |
| 2026-02-27 | Falcione Aaron | Chief Human Resources Officer | Grant | 24K | $0.00 | $0 | 87K |
| 2025-11-12 | COX CARRIE SMITH | Executive Chair | Buy | 65K | $7.67 | $502K | 78K |
| 2025-11-07 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Tax withholding | 1K | $6.71 | $8K | 17K |
| 2025-11-07 | Holzbaur Lynette | SVP and Corporate Controller | Tax withholding | 689 | $6.71 | $5K | 15K |
| 2025-11-07 | Holzbaur Lynette | SVP and Corporate Controller | Exercise or conversion | 2K | $0.00 | $0 | 15K |
| 2025-11-07 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Tax withholding | 2K | $6.71 | $15K | 29K |
| 2025-11-07 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Exercise or conversion | 6K | $0.00 | $0 | 31K |
| 2025-11-07 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Tax withholding | 1K | $6.71 | $8K | 20K |
| 2025-11-07 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Exercise or conversion | 4K | $0.00 | $0 | 18K |
| 2025-11-05 | Holzbaur Lynette | SVP and Corporate Controller | Tax withholding | 866 | $6.52 | $6K | 13K |
| 2025-11-05 | Holzbaur Lynette | SVP and Corporate Controller | Exercise or conversion | 3K | $0.00 | $0 | 14K |
| 2025-08-11 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Tax withholding | 4K | $9.22 | $38K | 25K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for OGN worth $553K at the prices reported; 1 in the last 90 days worth $200K. Latest: JULIANA P DRINANE filed on 2026-08-05 to sell 14,761 shares ($200K) from 2026-08-05.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-05 | JULIANA P DRINANEOfficer | 15K | $200K | 0.006% | 2026-08-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-08 | Holzbaur LynetteAffiliate | 26K | $353K | 0.010% | 2026-05-06 | Morgan Stanley Global Stock Plan Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of OGN in their latest filing, all on Schedule 13G (passive). The largest reported stake is Pentwater Capital Management LP at 6.9% of the class (18,100,000 shares), filed 2026-08-14 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G | Pentwater Capital Management LPinvestment adviser, partnership | 18.1M | 6.9% | 2026-06-30 |
| 2026-08-14 | 13G | Matthew Halbowerparent holding company, individual | 18.1M | 6.9% | 2026-06-30 |
| 2026-07-31 | 13G/Ano. 1 | Vanguard Portfolio Managementinvestment adviser | 15.2M | 5.8% | 2026-06-30 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 13.7M | 5.3% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 5 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding OGN at their latest 13F. JSON5 of the 30 tracked managers held OGN at their latest 13F, $81.1M in total at quarter-end prices. Millennium Management is the largest at $46.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 5 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 3.4M | $46.6M | 0.02% | -3.3M |
| AQR Capital Management | 2026-06-30 | 1.2M | $16.8M | 0.01% | -2.2M |
| D. E. Shaw & Co. | 2026-06-30 | 719K | $9.7M | 0.00% | -1.9M |
| Citadel Advisors | 2026-06-30 | 344K | $4.7M | 0.00% | -1.7M |
| Two Sigma Investments | 2026-06-30 | 241K | $3.3M | 0.00% | -2.9M |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q3 FY 2026 (quarter ended 2026-09-30) Organon reported revenue of $1.57B, down 1.7% from the same quarter a year earlier, and net income of $164.0M (0.60 diluted EPS). In FY 2025 it generated $700.0M of operating cash flow and spent $88.0M on dividends. As of 2026-09-30, cash was $1.46B against $8.55B of debt.
- Cash
- $1.46B
- Debt
- $8.55B
- Equity
- $1.19B
- Total assets
- $13.40B
- Shares outstanding
- 262,621,584
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q3 FY 2026 | 2026-09-30 | $1.57B | $164.0M | 10.4% | 0.60 |
| Q2 FY 2026 | 2026-06-30 | $1.56B | $108.0M | 6.9% | 0.40 |
| Q1 FY 2026 | 2026-03-31 | $1.46B | $146.0M | 10.0% | 0.55 |
| Q4 FY 2025derived | 2025-12-31 | $1.51B | -$205.0M | -13.6% | n/a |
| Q3 FY 2025 | 2025-09-30 | $1.60B | $160.0M | 10.0% | 0.61 |
| Q2 FY 2025 | 2025-06-30 | $1.59B | $145.0M | 9.1% | 0.56 |
| Q1 FY 2025 | 2025-03-31 | $1.51B | $87.0M | 5.8% | 0.33 |
| Q4 FY 2024derived | 2024-12-31 | $1.59B | $109.0M | 6.8% | n/a |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $6.22B | $187.0M | $700.0M | $162.0M | n/a | $88.0M |
| FY 2024 | 2024-12-31 | $6.40B | $864.0M | $939.0M | $175.0M | n/a | $297.0M |
| FY 2023 | 2023-12-31 | $6.26B | $1.02B | $799.0M | $251.0M | n/a | $294.0M |
| FY 2022 | 2022-12-31 | $6.17B | $917.0M | $858.0M | $196.0M | n/a | $290.0M |
| FY 2021 | 2021-12-31 | $6.30B | $1.35B | n/a | $192.0M | n/a | $145.0M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-09-30; shares outstanding as of 2026-10-23 from the cover page.
What this page is
Organon in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Organon (OGN), SEC CIK 1821825, listed on NYSE, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-07.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-05.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-09-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-04-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-11.JSON and CSV
- Company record
- EDGAR filing index for CIK 1821825Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of OGN is sold short?
18,817,326 shares were held short at the 2026-10-15 settlement, 8.6 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is OGN's daily short volume?
On 2026-11-02, 344,281 of the 917,236 OGN shares reported to FINRA were sold short, 37.5% of the day's reported volume. Short volume is a flow for one day, not a position.
Does OGN have fails to deliver?
The SEC's latest file shows 475 OGN shares failed to deliver at settlement 2026-10-07. Fails are reported per settlement date and published twice a month with a lag.
Are OGN insiders buying or selling?
Insiders at OGN reported 1 open-market sell worth $200K in the last 90 days and no open-market buys. Latest filing: Arjona Ferreira Juan Camilo (Head of R&D & CMO) on 2026-08-11.
Have OGN insiders filed to sell?
2 Form 144 notices on file for OGN worth $553K at the prices reported; 1 in the last 90 days worth $200K. Latest: JULIANA P DRINANE filed on 2026-08-05 to sell 14,761 shares ($200K) from 2026-08-05.
Who owns 5% or more of OGN?
4 holders report 5% or more of OGN in their latest filing, all on Schedule 13G (passive). The largest reported stake is Pentwater Capital Management LP at 6.9% of the class (18,100,000 shares), filed 2026-08-14 for an event on 2026-06-30.
What did OGN report last quarter?
In Q3 FY 2026 (quarter ended 2026-09-30) Organon reported revenue of $1.57B, down 1.7% from the same quarter a year earlier, and net income of $164.0M (0.60 diluted EPS). In FY 2025 it generated $700.0M of operating cash flow and spent $88.0M on dividends. As of 2026-09-30, cash was $1.46B against $8.55B of debt.
Which tracked 13F managers own OGN?
5 of the 30 tracked 13F managers held OGN shares at their latest filing, $81.1M in all. The largest: Izzy Englander's Millennium Management (3.4M shares, $46.6M), Cliff Asness's AQR Capital Management (1.2M shares, $16.8M), D. E. Shaw & Co. (719K shares, $9.7M), Ken Griffin's Citadel Advisors (344K shares, $4.7M), Two Sigma Investments (241K shares, $3.3M).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.